Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

OBJECTIVES: To investigate the pharmacokinetics of darunavir/ritonavir and raltegravir, in HIV-infected subjects, in both plasma and at the intracellular (IC) site of action. METHODS: HIV-infected patients on antiretroviral therapy received raltegravir 400 mg twice daily for 21 days (period 1); daru...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jackson, Akil, Watson, Victoria, Back, David, Khoo, Saye, Liptrott, Neill, Egan, Deidre, Gedela, Keerti, Higgs, Chris, Abbas, Riaz, Gazzard, Brian, Boffito, Marta
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594701/
https://ncbi.nlm.nih.gov/pubmed/21926632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182364c67
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы